The COX-2 inhibitor celecoxib was found to have a significant positive effect on major depression, not only in single studies but also in meta-analyses.
This study investigated the effects of BanI polymorphism of cPLA2 gene and COX-2rs4648308 genotypes on somatic symptoms and inflammatory marker in patients with MDD.